Abstract:Abstract Alterations of nuclear genes in human disease or tumors have been well investigated in past several decades and unequivocally established a predominant role in the pathogenesis. However, the relationship of mitochondrial genome alteration or dysfunction and human disease or tumor remains large unknown. Mitochondria are dynamic organelles involved in oxidative phosphorylation and production of reactive oxygen species (ROS). Accumulated evidence supports that mitochondrial DNA damage and dysfunction play vital roles in the development of a wide array of mitochondria-related diseases, such as obesity, diabetes, infertility, neurodegenerative disorders and malignant tumors in human. We previously described the development of a transgenic (TG) mouse model for mitochondrial damage by overexpressing human mitochondrial isoform of 8-oxoguanine DNA Glycosylase 1 (hOGG1) gene (Blood108:A 2246, 2006). The TG mice developed early onset obesity, female infertility, very high frequencies of B-cell lymphomas and human essential thrombocythemia like myeloproliferative disorders. We now reported here that major mitochondrial DNA deletions were frequently identified in a variety of organs in these hOGG1 TG mice and these deletions may largely contribute to the biologic phenotypes of the TG mice. The development and characterization of hOGG1 TG mice have been described previously. In the current study, mitochondrial DNA samples were extracted from various organs and tumor tissues of hOGG1 TG and age-matched non-TG control animals and subjected to PCR analysis using 8 specific primer sets franking the breakpoints of 7 major mitochondrial DNA deletions. Six deletions (3.7, 3.82, 3.86, 4.2, 4.9 and 5.2 kilobase in length) have been previously reported in the literatures. One novel deletion of 15.kilobase was identified in hOGG1 TG mouse in our laboratory. Among 7 major mitochondrial DNA deletion analyzed, Five (3.7, 3.86, 4.2, 5.2 and 15 kilobase in length) deletions were detected in higher frequency in various organs of hOGG1 TG but not in non-TG control mice, suggesting that those deletions might be resulted from overexpression of the transgene hOGG1. Notably, 3 deletions (del3729, del3868, and del15139) were identified in significantly higher in TG mouse spleen with myeloproliferative disorders or TG mouse spleen with diffuse large B-cell lymphoma, in comparison to the spleen of the age-matched wild type animals (P<0.01). Accordingly, protein expression of major mitochondrial complexes were also significantly reduced in hOGG1 TG mice. Furthermore, major mitochondrial DNA deletion due to overexpressed hOGG1 leading to imbalanced mitochondrial DNA base excision repair pathways resulted in defects in mitochondrial respiration and significantly increased in ROS production in those TG mice. We therefore concluded that major mitochondrial DNA deletions with resultant reduced mitochondrial protein expression, mitochondrial dysfunction and increased in ROS production may represent an important molecular mechanism by which these hOGG TG mice develop obesity, infertility and hematologic malignancies.

Deletion of Mocos Induces Xanthinuria with Obstructive Nephropathy and Major Metabolic Disorders in Mice.

Mechanistic Study on the Nuclear Modifier Gene MSS1 Mutation Suppressing Neomycin Sensitivity of the Mitochondrial 15S Rrna C1477G Mutation in Saccharomyces Cerevisiae.

Case Report: Compound Heterozygous Variants in MOCS3 Identified in a Chinese Infant With Molybdenum Cofactor Deficiency

Deletion of the Uox gene generates a mouse model of hyperuricemia with cardiovascular complications

Major Mitochondrial Dna Deletions In Transgenic Mice Overexpressing A Human 8-Oxoguanine Dna-Glycosylase Leading To High Frequency Of Lymphoma And Myeloproliferative Disorder

Kidney Failure Secondary to Hereditary Xanthinuria due to a Homozygous Deletion of the XDH Gene in the Absence of Overt Kidney Stone Disease

Sulfite Alters the Mitochondrial Network in Molybdenum Cofactor Deficiency

Mutation in the MICOS subunit gene APOO (MIC26) associated with an X-linked recessive mitochondrial myopathy, lactic acidosis, cognitive impairment and autistic features

Deciphering pathophysiological mechanisms underlying cystathionine beta-synthase-deficient homocystinuria using targeted metabolomics, liver proteomics, sphingolipidomics and analysis of mitochondrial function

Loss of the BMP Antagonist, SMOC-1, Causes Ophthalmo-Acromelic (Waardenburg Anophthalmia) Syndrome in Humans and Mice

Implication of folate deficiency in CYP2U1 loss of function

CRISPR/Cas9 Mediated Deletion of the Uox Gene Generates a Mouse Model of Hyperuricemia with Multiple Complications

Mice deficient in UXT exhibit retinitis pigmentosa-like features via aberrant autophagy activation

Chances and challenges of using routine data collections for renal health care research.

Mouse models to study the pathophysiology of combined methylmalonic acidemia and homocystinuria, cblC type

A mouse model of early-onset renal failure due to a xanthine dehydrogenase nonsense mutation

Early postnatal ataxia and abnormal cerebellar development in mice lacking Xeroderma pigmentosum Group A and Cockayne Syndrome Group B DNA repair genes

Nifuroxazide rescues the deleterious effects due to CHCHD10 -associated MICOS defects in disease models

Slc35a2 mosaic knockout impacts cortical development, dendritic arborisation, and neuronal firing

Congenital microcoria deletion in mouse links Sox21 dysregulation to disease and suggests a role for TGFB2 in glaucoma and myopia

Germline Saturation Mutagenesis Induces Skeletal Phenotypes in Mice